NeuroMarkers最新文献

筛选
英文 中文
Spontaneous Isomerization of Tau is Most Prevalent in Alzheimer's Disease. Tau自发异构化在阿尔茨海默病中最为普遍。
NeuroMarkers Pub Date : 2026-06-01 Epub Date: 2026-04-15 DOI: 10.1016/j.neumar.2025.100152
Evan E Hubbard, Kevin Reagle, Matthew K Lui, Maxence Derbez-Morin, Gennifer E Merrihew, Michael J MacCoss, Ryan R Julian
{"title":"Spontaneous Isomerization of Tau is Most Prevalent in Alzheimer's Disease.","authors":"Evan E Hubbard, Kevin Reagle, Matthew K Lui, Maxence Derbez-Morin, Gennifer E Merrihew, Michael J MacCoss, Ryan R Julian","doi":"10.1016/j.neumar.2025.100152","DOIUrl":"10.1016/j.neumar.2025.100152","url":null,"abstract":"<p><p>Alzheimer's disease is the most common cause of dementia in humans and has been the subject of intense study for decades. Despite these efforts, the precise underlying cause or causes of Alzheimer's disease have remained elusive. Here we implement novel analysis of mass-spectrometry derived proteomics data to examine an understudied phenomenon related to Alzheimer's disease, isomerization of the protein tau. Isomerization is a spontaneous chemical modification that occurs in long-lived proteins and evolves most rapidly at aspartic acid. Recent results have demonstrated that isomerization of tau is more prevalent in Alzheimer's disease relative to healthy controls. To further map out the importance of tau isomerization in neurodegeneration, we examined its prevalence in several additional diseases by mining publicly available datasets and our own results, allowing for examination of Parkinson's disease, Lewy body dementia, vascular brain injury, and chronic traumatic encephalopathy. To evaluate the extent of tau isomerization in various locations within the brain in Alzheimer's disease, we examined samples from the frontal cortex, anterior cingulate gyrus, inferior parietal lobule, and caudate. Interestingly, our results demonstrate that significant isomerization of tau occurs only in individuals with Alzheimer's disease. In terms of localization, tau was easily detected in all regions of the brain, and tau isomerization was detected for Alzheimer's disease in all regions except the caudate. Importantly, tau isomerization can be easily and rigorously quantified from proteomics data. Comparison of the extent of tau isomerization with pre-mortem performance on the Mini-Mental State Examination revealed strong correlation. In addition to minimal abundance in other forms of neurodegeneration, tau isomerization was also low for a small number of the individuals designated to have Alzheimer's disease in our study, however consideration of other factors such as genetic predisposition, age, and mental acuity also differentiates these individuals. Importantly, the amount of tau isomerization observed in our studies does not correlate in any meaningful way with tau aggregation. Collectively, these observations suggest that tau isomerization derives from a different pathogenesis than other neurodegenerative markers, one that is only prevalent in Alzheimer's disease and may offer means for delineating the underlying causes of the disease.</p>","PeriodicalId":523844,"journal":{"name":"NeuroMarkers","volume":"3 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13309227/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148348779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biases and consistency of different assay methods for neurological biomarkers using Quanterix single-molecule-array technology: A secondary analysis method comparison study. 使用Quanterix单分子阵列技术测定神经生物标志物的不同分析方法的偏差和一致性:二级分析方法比较研究。
NeuroMarkers Pub Date : 2026-03-01 Epub Date: 2025-11-19 DOI: 10.1016/j.neumar.2025.100147
K Danielle Go, Jamie Hutchison, Kevin Wang, Thomas K Karikari, Stefania Mondello, Ramon Diaz-Arrastia, Ava Puccio, Sophie Stukas, Jennifer G Cooper, Cheryl L Wellington
{"title":"Biases and consistency of different assay methods for neurological biomarkers using Quanterix single-molecule-array technology: A secondary analysis method comparison study.","authors":"K Danielle Go, Jamie Hutchison, Kevin Wang, Thomas K Karikari, Stefania Mondello, Ramon Diaz-Arrastia, Ava Puccio, Sophie Stukas, Jennifer G Cooper, Cheryl L Wellington","doi":"10.1016/j.neumar.2025.100147","DOIUrl":"10.1016/j.neumar.2025.100147","url":null,"abstract":"<p><p>Breakthrough technologies such as the Single molecule array (Simoa) technology developed by Quanterix provide higher sensitivity, enabling measurement of central nervous system-abundant proteins in blood. Neurofilament light chain (NfL) and glial fibrillary protein (GFAP) are two proteins that have attracted considerable attention as biomarkers for many neurological conditions. Due to their performance and utility, these biomarkers are available in different Quanterix assays, including single-plex and multi-plex assay setups. Limited research has been conducted to evaluate how modifications in assay formulations may impact overall analytical performance and comparability. We recently established reference intervals (RI) for plasma NfL and GFAP measured in normative samples from the Canadian Health Measures Survey (CHMS) using the Quanterix Neurology 4-Plex E (N4PE) Advantage. The aim of the present study was to perform method comparisons to assess how well CHMS RIs generated on the N4PE assay translate to other assay formulations to facilitate generalizability and uptake. Seven independent comparisons were conducted, each using a total of 80 plasma samples from the CHMS. These samples were divided (n=40 each) based on the two N4PE lots previously used to generate RIs. The following Quanterix assay formulations were evaluated against the N4PE anchor assay: NfL Advantage PLUS (NfL+), GFAP Advantage PLUS (GFAP+), Neurology 2-Plex B Advantage (N2PB), Neurology 2-Plex B Advantage PLUS (N2PB+), Neurology 4-Plex B Advantage (N4PB), Neurology 4-Plex D PLUS (N4PD+), and Neurology 4-Plex E PLUS (N4PE+). Plasma biomarker concentrations were measured using the Quanterix Simoa HD-X analyzer, with assays run as per the manufacturer's specifications. Assay comparisons were conducted using Spearman correlation and Bland-Altman analysis to assess bias between assays. Both NfL and GFAP concentrations were tightly correlated between assay formulations with rho > 0.9 and a P-value < 0.0001 for all assay crosses. However, the bias between formulations ranged from 0.5% to 42.1%, indicating that data correction may be required to harmonize data generated from different assay formulations. In summary, this study emphasizes the importance of data correction when using different assay methods to ensure data comparability across studies. Additionally, the study results support the applicability of RIs and suggest that when using RIs, corrections should be made based on the assay-specific bias. Future studies should further expand the sample range, particularly in high-concentration conditions such as acute neurological injury, to comprehensively evaluate the performance of different assay formulations.</p>","PeriodicalId":523844,"journal":{"name":"NeuroMarkers","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13166133/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147937261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书